An Overview of iQOS(®) as a New Heat-Not-Burn Tobacco Product and Its Potential Effects on Human Health and the Environment

Por BAŞARAN, Rahman, GÜVEN, Naile Merve, EKE, Benay Can
Publicado no Turk J Pharm Sci (2019)

The progamic phase of an early-divergent angiosperm, Annona cherimola (Annonaceae)

Por Lora, J., Hormaza, J. I., Herrero, M.
Publicado em 2010

Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC)

Por Kraus, K. M., Oechsner, M., Wilkens, J. J., Kessel, K. A., Münch, S., Combs, S. E.
Publicado no Sci Rep (2021)

Comparing the Efficacy of Drug Regimens for Pulmonary Tuberculosis: Meta-analysis of Endpoints in Early-Phase Clinical Trials

Por Bonnett, Laura J, Ken-Dror, Gie, Koh, Gavin C K W, Davies, Geraint R
Publicado no Clin Infect Dis (2017)

Comparison of hierarchical EMAX and NDLM models in dose-response for early phase clinical trials

Por Xiaqing Huang, Byron J. Gajewski
Publicado em 2020-07-01

Comparison of hierarchical EMAX and NDLM models in dose-response for early phase clinical trials

Por Huang, Xiaqing, Gajewski, Byron J.
Publicado no BMC Med Res Methodol (2020)

Surgery With or Without Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung...

Por Pisters, Katherine M.W., Vallières, Eric, Crowley, John J., Franklin, Wilbur A., Bunn, Paul A., Ginsberg, Robert J., Putnam, Joe B., Chansky, Kari, Gandara, David
Publicado em 2010

PHASE II STUDY OF CELECOXIB AND DOCETAXEL IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH PROGRESSION AFTER PLATINUM-BASED THERAPY

Por Schneider, Bryan J., Kalemkerian, Gregory P., Kraut, Michael J., Wozniak, Antoinette J., Worden, Francis P., Smith, Daryn W., Chen, Wei, Gadgeel, Shirish M.
Publicado em 2008

Cone Photoreceptor Dysfunction in Early-Stage Diabetic Retinopathy: Association Between...

Por McAnany, J. Jason, Park, Jason C.
Publicado no Invest Ophthalmol Vis Sci (2019)

P13.05 Success Rate and Early Morbidity from Image-Guided Ommaya Reservoir Placement for Intraventricular Chemotherapy: Case Series and Systematic Review

Por Lau, J. C., Macdonald, D. R., Megyesi, J. F.
Publicado no Neuro Oncol (2016)

A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative...

Por Hamre, Harald J, Pham, Van N, Kern, Christian, Rau, Rolf, Klasen, Jörn, Schendel, Ute, Gerlach, Lars, Drabik, Attyla, Simon, Ludger
Publicado no Patient Prefer Adherence (2018)

Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug Trials

Por van den Bogert, Cornelis A., Souverein, Patrick C., Brekelmans, Cecile T. M., Janssen, Susan W. J., Koëter, Gerard H., Leufkens, Hubert G. M., Bouter, Lex M.
Publicado no PLoS One (2016)

Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel...

Por Langer, Corey J., Novello, Silvia, Park, Keunchil, Krzakowski, Maciej, Karp, Daniel D., Mok, Tony, Benner, Rebecca J., Scranton, Judith R., Olszanski, Anthony J., Jassem, Jacek
Publicado em 2014

Improved power for TB Phase IIa trials using a model-based pharmacokinetic–pharmacodynamic approach compared with commonly used analysis methods

Por Svensson, Robin J., Gillespie, Stephen H., Simonsson, Ulrika S. H.
Publicado no J Antimicrob Chemother (2017)

174.1 Neurocognition and Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study

Por Seidman, Larry J.
Publicado no Schizophr Bull (2017)

Phase I/II Trial of Immunotherapy with Durvalumab and Tremelimumab With Continuous or Intermittent MEK Inhibitor Selumetinib in NSCLC: Early trial report

Por Gaudreau, Pierre-Olivier, Lee, J. Jack, Heymach, John V., Gibbons, Don L.
Publicado no Clin Lung Cancer (2020)

Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin

Por Ploquin, A, Olmos, D, Lacombe, D, A'Hern, R, Duhamel, A, Twelves, C, Marsoni, S, Morales-Barrera, R, Soria, J-C, Verweij, J, Voest, E E, Schöffski, P, Schellens, J H, Kramar, A, Kristeleit, R S, Arkenau, H-T, Kaye, S B, Penel, N
Publicado em 2012

Bayesian hierarchical EMAX model for dose-response in early phase efficacy clinical trials

Por Gajewski, Byron J., Meinzer, Caitlyn, Berry, Scott M., Rockswold, Gaylan L., Barsan, William G., Korley, Frederick K., Martin, Renee’ H.
Publicado no Stat Med (2019)

BACCHUS: A randomised non-comparative phase II study of neoadjuvant chemotherapy (NACT) in patients with locally advanced rectal cancer (LARC)

Por Glynne-Jones, R., Hall, M.R., Lopes, A., Pearce, S., Goh, V., Bosompem, S., Bridgewater, J., Chau, I., Wasan, H., Moran, B., Melcher, L., West, N.P., Quirke, P., Wong, W.-L., Beare, S., Hava, N., Duggan, M., Harrison, M.
Publicado no Heliyon (2018)

Decreased xanthine oxidoreductase is a predictor of poor prognosis in early‐stage gastric cancer

Por Linder, N, Haglund, C, Lundin, M, Nordling, S, Ristimäki, A, Kokkola, A, Mrena, J, Wiksten, J‐P, Lundin, J
Publicado em 2006